Hovione LLCJanuary 22, 2020

FDA 483 - Hovione LLC - January 22, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hovione LLC

Record Details

Hovione LLC, a manufacturer of Intermediates and Active Pharmaceutical Ingredients in East Windsor, NJ, was cited for two significant observations. The inspection revealed inadequate employee training, which was identified as the root cause for a substantial number of quality-related events. Additionally, the firm failed to thoroughly review unexplained discrepancies, including the use of incorrect or expired solutions in analytical testing.

Company: Hovione LLC
Inspection Date: January 22, 2020
Product Type: Drugs
Office: New Jersey District Office
Person: Adetutu M. Gidado

Open in Dashboard

ID · bf3e5a4c-c97c-47b5-a056-b7191dbd2226